{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:40:52Z","timestamp":1793418052810,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)","id":[{"id":"https:\/\/ror.org\/00f2yqf98","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To assess perioperative complications after native nephrectomy in autosomal dominant polycystic kidney disease (ADPKD), identify risk factors and evaluate surgical timing and approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 124 nephrectomy episodes in patients with ADPKD treated at a single tertiary center between October 2012 and October 2022. Complications were graded according to the Clavien\u2013Dindo classification. Multivariable logistic regression was used to assess predictors of overall and major complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Perioperative complications occurred in 73\/124 episodes (58.9%), including 31 major complications (25.0%). Lower preoperative hemoglobin independently predicted overall complications (OR 0.74 per g\/dL, 95% CI 0.61\u20130.89;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), whereas left-sided nephrectomy was associated with a lower overall complication risk (OR 0.25, 95% CI 0.09\u20130.72;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011). Diverticulosis independently predicted major complications (OR 5.03, 95% CI 1.76\u201314.33;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). Simultaneous bilateral nephrectomy showed the highest overall complication rate (69.7%). Open procedures were performed for markedly larger kidneys than minimally invasive procedures (median operative specimen weight 3518.5\u00a0g vs 495.5\u00a0g;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Minimally invasive surgery was not independently associated with a lower complication risk (OR 0.75, 95% CI 0.15\u20133.79;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.726).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Native nephrectomy in ADPKD is associated with substantial perioperative morbidity and should remain restricted to carefully selected patients. Surgical timing relative to transplantation should be guided primarily by symptoms and clinical necessity. Simultaneous bilateral nephrectomy appears to carry the greatest perioperative burden. Although minimally invasive surgery is feasible in selected patients with smaller kidneys, our data do not demonstrate an independent reduction in morbidity after adjustment for case complexity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11255-026-05155-8","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:31:46Z","timestamp":1776774706000},"page":"4039-4047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perioperative complications in native nephrectomy as a therapeutic approach for symptomatic polycystic kidney disease: a comprehensive study"],"prefix":"10.1007","volume":"58","author":[{"given":"Alireza","family":"Helal Birjandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouriya","family":"Faraj Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Idais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Kuczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Tezval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"5","key":"5155_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","volume":"67","author":"FT Chebib","year":"2016","unstructured":"Chebib FT, Torres VE (2016) Autosomal dominant polycystic kidney disease: core curriculum 2016. Am J Kidney Dis 67(5):792\u2013810. https:\/\/doi.org\/10.1053\/j.ajkd.2015.07.037","journal-title":"Am J Kidney Dis"},{"key":"5155_CR2","unstructured":"Harris PC, Torres VE (1993) Polycystic kidney disease, autosomal dominant. GeneReviews. Seattle (WA): University of Washington, Seattle"},{"issue":"6","key":"5155_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/ki.2014.120","volume":"86","author":"EM Spithoven","year":"2014","unstructured":"Spithoven EM, Kramer A, Meijer E et al (2014) Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney Int 86(6):1244\u20131252. https:\/\/doi.org\/10.1038\/ki.2014.120","journal-title":"Kidney Int"},{"issue":"3","key":"5155_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.21873\/invivo.11060","volume":"31","author":"C Argyrou","year":"2017","unstructured":"Argyrou C, Moris D, Vernadakis S (2017) Tailoring the \u201cperfect fit\u201d for renal transplant recipients with end-stage polycystic kidney disease: indications and timing of native nephrectomy. In Vivo 31(3):307\u2013312. https:\/\/doi.org\/10.21873\/invivo.11060","journal-title":"In Vivo"},{"key":"5155_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321\u2013337. https:\/\/doi.org\/10.1146\/annurev.med.60.101707.125712","journal-title":"Annu Rev Med"},{"issue":"2","key":"5155_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/ndt\/gft437","volume":"29","author":"RL Luciano","year":"2014","unstructured":"Luciano RL, Dahl NK (2014) Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant 29(2):247\u2013254. https:\/\/doi.org\/10.1093\/ndt\/gft437","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"5155_CR7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1097\/01.ju.0000181208.06507.aa","volume":"174","author":"TF Fuller","year":"2005","unstructured":"Fuller TF, Brennan TV, Feng S et al (2005) End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol 174(6):2284\u20132288. https:\/\/doi.org\/10.1097\/01.ju.0000181208.06507.aa","journal-title":"J Urol"},{"issue":"2","key":"5155_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/ndt\/gfs118","volume":"28","author":"HP Neeff","year":"2013","unstructured":"Neeff HP, Pisarski P, Tittelbach-Helmrich D et al (2013) One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 28(2):466\u2013471. https:\/\/doi.org\/10.1093\/ndt\/gfs118","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"5155_CR9","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.transproceed.2018.02.100","volume":"50","author":"M Jankowska","year":"2018","unstructured":"Jankowska M, Ku\u017amiuk-Glembin I, Skonieczny P, D\u0119bska-\u015alizie\u0144 A (2018) Native nephrectomy in renal transplant recipients with autosomal dominant polycystic kidney disease. Transplant Proc 50(6):1863\u20131867. https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.100","journal-title":"Transplant Proc"},{"issue":"6","key":"5155_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jamcollsurg.2017.11.021","volume":"226","author":"RA Jean","year":"2018","unstructured":"Jean RA, Alexandre M, Yoo PS (2018) Kidney transplantation with and without native nephrectomy for polycystic kidney disease: results of the National Inpatient Sample and the rationale for a 2-staged procedure. J Am Coll Surg 226(6):1079\u20131084. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.11.021","journal-title":"J Am Coll Surg"},{"issue":"10","key":"5155_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000554","volume":"1","author":"FT Chebib","year":"2015","unstructured":"Chebib FT, Prieto M, Jung Y et al (2015) Native nephrectomy in renal transplant recipients with autosomal-dominant polycystic kidney disease. Transplant Direct 1(10):e43. https:\/\/doi.org\/10.1097\/TXD.0000000000000554","journal-title":"Transplant Direct"},{"issue":"6","key":"5155_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129317","volume":"10","author":"P Guo","year":"2015","unstructured":"Guo P, Xu W, Li H, Ren T, Ni S, Ren M (2015) Laparoscopic nephrectomy versus open nephrectomy for patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis. PLoS ONE 10(6):e0129317. https:\/\/doi.org\/10.1371\/journal.pone.0129317","journal-title":"PLoS ONE"},{"issue":"5","key":"5155_CR13","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.juro.2010.06.150","volume":"184","author":"SM Lucas","year":"2010","unstructured":"Lucas SM, Mofunanya TC, Goggins WC, Sundaram CP (2010) Staged nephrectomy versus bilateral laparoscopic nephrectomy in patients with autosomal dominant polycystic kidney disease. J Urol 184(5):2054\u20132059. https:\/\/doi.org\/10.1016\/j.juro.2010.06.150","journal-title":"J Urol"},{"issue":"4","key":"5155_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00464-005-0229-z","volume":"20","author":"MG Whitten","year":"2006","unstructured":"Whitten MG, Van der Werf W, Belnap L (2006) A novel approach to bilateral hand-assisted laparoscopic nephrectomy for autosomal dominant polycystic kidney disease. Surg Endosc 20(4):679\u2013684. https:\/\/doi.org\/10.1007\/s00464-005-0229-z","journal-title":"Surg Endosc"},{"issue":"2","key":"5155_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4293\/108680813X13654754535719","volume":"17","author":"M Eng","year":"2013","unstructured":"Eng M, Jones CM, Cannon RM, Marvin MR (2013) Hand-assisted laparoscopic nephrectomy for polycystic kidney disease. JSLS 17(2):279\u2013284. https:\/\/doi.org\/10.4293\/108680813X13654754535719","journal-title":"JSLS"},{"issue":"2","key":"5155_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000513168","volume":"145","author":"AE Lubennikov","year":"2021","unstructured":"Lubennikov AE, Petrovskii NV, Krupinov GE et al (2021) Bilateral nephrectomy in patients with autosomal dominant polycystic kidney disease and end-stage chronic renal failure. Nephron 145(2):164\u2013170. https:\/\/doi.org\/10.1159\/000513168","journal-title":"Nephron"},{"issue":"5","key":"5155_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1308\/003588411X582690","volume":"93","author":"P Patel","year":"2011","unstructured":"Patel P, Horsfield C, Compton F, Taylor J, Koffman G, Olsburgh J (2011) Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease. Ann R Coll Surg Engl 93(5):391\u2013395. https:\/\/doi.org\/10.1308\/003588411X582690","journal-title":"Ann R Coll Surg Engl"},{"issue":"20","key":"5155_CR18","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB et al (2006) Volume progression in polycystic kidney disease. N Engl J Med 354(20):2122\u20132130. https:\/\/doi.org\/10.1056\/NEJMoa054341","journal-title":"N Engl J Med"},{"issue":"4","key":"5155_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.5527\/wjn.v4.i4.468","volume":"4","author":"JA Akoh","year":"2015","unstructured":"Akoh JA (2015) Current management of autosomal dominant polycystic kidney disease. World J Nephrol 4(4):468\u2013479. https:\/\/doi.org\/10.5527\/wjn.v4.i4.468","journal-title":"World J Nephrol"},{"issue":"4","key":"5155_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1464-410X.2010.09938.x","volume":"108","author":"MA Kirkman","year":"2011","unstructured":"Kirkman MA, van Dellen D, Mehra S et al (2011) Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation? BJU Int 108(4):590\u2013594. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09938.x","journal-title":"BJU Int"},{"issue":"2","key":"5155_CR21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.transproceed.2004.12.115","volume":"37","author":"J Rozanski","year":"2005","unstructured":"Rozanski J, Kozlowska I, Myslak M et al (2005) Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease. Transplant Proc 37(2):666\u2013668. https:\/\/doi.org\/10.1016\/j.transproceed.2004.12.115","journal-title":"Transplant Proc"},{"issue":"2","key":"5155_CR22","first-page":"15","volume":"1","author":"E Brazda","year":"1996","unstructured":"Brazda E, Ofner D, Riedmann B, Spechtenhauser B, Margreiter R (1996) The effect of nephrectomy on the outcome of renal transplantation in patients with polycystic kidney disease. Ann Transplant 1(2):15\u201318 (DOI not verified)","journal-title":"Ann Transplant"},{"issue":"6","key":"5155_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00423-020-01939-3","volume":"405","author":"BM J\u00e4nigen","year":"2020","unstructured":"J\u00e4nigen BM, Hempel J, Holzner P et al (2020) Simultaneous ipsilateral nephrectomy during kidney transplantation in autosomal dominant polycystic kidney disease: a matched pair analysis of 193 consecutive cases. Langenbecks Arch Surg 405(6):833\u2013842. https:\/\/doi.org\/10.1007\/s00423-020-01939-3","journal-title":"Langenbecks Arch Surg"},{"issue":"12","key":"5155_CR24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/17434440.2024.2435546","volume":"21","author":"G Bignante","year":"2024","unstructured":"Bignante G, Orsini A, Lasorsa F et al (2024) Robotic-assisted surgery for the treatment of urologic cancers: recent advances. Expert Rev Med Devices 21(12):1165\u20131177. https:\/\/doi.org\/10.1080\/17434440.2024.2435546","journal-title":"Expert Rev Med Devices"},{"issue":"4","key":"5155_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/TP.0b013e31825812b9","volume":"94","author":"MH Skauby","year":"2012","unstructured":"Skauby MH, \u00d8yen O, Hartman A, Leivestad T, Wadstr\u00f6m J (2012) Kidney transplantation with and without simultaneous bilateral native nephrectomy in patients with polycystic kidney disease: a comparative retrospective study. Transplantation 94(4):383\u2013388. https:\/\/doi.org\/10.1097\/TP.0b013e31825812b9","journal-title":"Transplantation"},{"key":"5155_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.euros.2023.04.011","volume":"52","author":"A Pecoraro","year":"2023","unstructured":"Pecoraro A, Roussel E, Amparore D et al (2023) New-onset chronic kidney disease after surgery for localised renal masses in patients with two kidneys and preserved renal function: a contemporary multicentre study. Eur Urol Open Sci 52:100\u2013108. https:\/\/doi.org\/10.1016\/j.euros.2023.04.011","journal-title":"Eur Urol Open Sci"},{"issue":"12","key":"5155_CR27","doi-asserted-by":"publisher","first-page":"487.e15","DOI":"10.1016\/j.urolonc.2023.09.015","volume":"41","author":"C Saitta","year":"2023","unstructured":"Saitta C, Afari JA, Autorino R et al (2023) Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: a multicenter analysis. Urol Oncol 41(12):487.e15-487.e23. https:\/\/doi.org\/10.1016\/j.urolonc.2023.09.015","journal-title":"Urol Oncol"},{"issue":"1","key":"5155_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00345-014-1248-y","volume":"33","author":"A Breda","year":"2015","unstructured":"Breda A, Luccarelli G, Rodriguez-Faba O et al (2015) Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. World J Urol 33(1):1\u20137. https:\/\/doi.org\/10.1007\/s00345-014-1248-y","journal-title":"World J Urol"},{"issue":"3","key":"5155_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","volume":"74","author":"P Hajj","year":"2009","unstructured":"Hajj P, Ferlicot S, Massoud W et al (2009) Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74(3):631\u2013634. https:\/\/doi.org\/10.1016\/j.urology.2009.02.078","journal-title":"Urology"},{"issue":"1\u20132","key":"5155_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000351049","volume":"123","author":"CA Jilg","year":"2013","unstructured":"Jilg CA, Drendel V, Bacher J et al (2013) Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens. Nephron Clin Pract 123(1\u20132):13\u201321. https:\/\/doi.org\/10.1159\/000351049","journal-title":"Nephron Clin Pract"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05155-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05155-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05155-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:52:57Z","timestamp":1789631577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05155-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5155"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05155-8","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was reviewed by the Ethics Committee of Hannover Medical School, Hannover, Germany (reference 11090_BO_K_2023; 27 September 2023). The study was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived because of the retrospective design and the use of anonymized data, in accordance with local institutional requirements.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}